Preparation method of crisaborole

By using salicylic aldehyde as the starting material, using bromine reaction and borate esterification steps, combined with palladium catalysis, the efficient preparation of Ceriborole is achieved, and the problems of high costs and many side reactions in the existing technology are solved. Improve product purity and adaptability to industrial production.

CN119080812APending Publication Date: 2024-12-06JINING SHENGTAI PHARM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411422936.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-12
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The existing preparation method of Ceriborol has problems such as high cost, many side reactions, low purity and harsh reaction conditions, especially the use of expensive raw materials 2-bromo-5-hydroxybenzaldehyde and extremely active n-butyllithium , difficult to be suitable for industrial production.

Method used

Using salicyaldehyde as the starting material, through bromine reaction, trifluoromethanesulfonate esterification, etherification and borate esterification steps, combined with palladium catalysis and alkaline conditions, avoiding hydroxyl or bromine participation in borate esterification reaction , realize the process flow of ether-forming and then cyclizing.

Benefits of technology

It reduces raw material costs, reduces side reactions, improves product purity, meets the needs of industrial production, has mild reaction conditions, simple post-processing, and is environmentally friendly.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The invention relates to a preparation method of crisaborole, and belongs to the technical field of chemical medicine preparation. Salicylaldehyde (formula I) is used as a raw material, and the crisaborole is finally obtained through bromination, hydroxyl protection, etherification, reduction, cyclization and other reactions. According to the present invention, the cheap and easily available salicylaldehyde is adopted as the starting material, such that the cost is low, the yield is high, the participation of hydroxyl or bromine in the boric acid esterification reaction is avoided, the side reaction is less, the reaction condition is mild, the post-treatment is simple, the environmental protection is provided, and the industrial production requirement can be met.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a preparation method of crisaborole, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]benzonitrile, and belongs to the technical field of chemical drug preparation. Background Art

[0002]

[0003] Clisborole is a new type of small molecule, non-hormonal, non-steroidal anti-inflammatory phosphodiesterase 4 (PDE-4) inhibitor, originally developed by Anacor. In June 2016, Pfizer acquired Anacor (Anacor developed Clisborole); in December 2016, Clisborole was approved by the US FDA for the treatment of mild to moderate AD in children over 2 years old and adults; on March 25, 2020, Pfizer announced that the FDA has approved the extension of the minimum age for Clisborole to treat AD from 2 years old to over 3 months old. Clisborole became the first and only non-steroidal topical prescription drug suitable for patients with mild to moderate AD as young as 3 months old; in March 2020, the European Commission also approved Clisborole for the treatment of mild to moderate AD over 2 years old with skin lesions <40%; on July 29, 2020, Clisborole was approved by the China National Medical Products Administration for the treatment of mild to moderate AD over 2 years old.

[0004] At present, most of the preparation methods of this compound use 2-bromo-5-hydroxybenzaldehyde as the starting material. Under alkaline conditions, the phenolic hydroxyl group and the aldehyde group will undergo self-condensation, and will also undergo self-condensation with bromine.

[0005] The original research route is a patent for a series of small molecule compounds containing boron applied for by Anacor Pharmaceuticals of the United States through the PCT route in 2006. The international publication number is WO2006089067A2, and the Chinese equivalent patent number is CN101914109B. The process is shown below.

[0006]

[0007] This route uses ethylene glycol to protect the aldehyde group, and then deprotects it under acidic conditions after etherification, which has complicated steps. It uses highly active n-butyl lithium, which is flammable and explosive and has low safety. The reaction must be carried out in anhydrous, oxygen-free and low-temperature conditions of ~78°C. The reaction conditions are relatively harsh and not conducive to industrial production. In addition, the raw material price of 2-bromo-5-hydroxybenzaldehyde is relatively expensive, with a market price ranging from 1,000 to 3,000 yuan / kg, and the material cost is relatively high.

[0008] Chinese patent CN106928264A introduces a synthetic route of crisaborole, as shown below.

[0009]

[0010] This route forms a ring first and then forms an ether, avoiding the use of toxic reagents and expensive intermediates. However, the presence of phenolic hydroxyl groups during the reaction of 3a and 3b will induce many side reactions, making compound 3c difficult to purify. In addition, the raw material 2-bromo-5-hydroxybenzaldehyde is expensive, resulting in high material costs.

[0011] Chinese patent CN108047261A introduces a synthetic route of crisaborole, as shown below.

[0012]

[0013] This route uses compound IV as the starting material, and produces criborole through hydroxyl protection, borate esterification, and cyclization reaction. The protection and deprotection steps are cumbersome, increasing the production cost; the synthesis of compound IV will inevitably produce diether impurity A, which is converted into impurity B in the borate esterification reaction and converted into impurity C in the final cyclization reaction, affecting the purity of the product. Using compound IV as the starting material will greatly increase the production cost and is not suitable for commercial production.

[0014]

[0015] Therefore, a new technical solution is urgently needed to optimize the relevant process conditions from the perspectives of cost, etherification reaction, impurity control, etc., to improve purity, reduce side reactions, and minimize production costs. Summary of the invention

[0016] In order to overcome the above problems existing in the prior art, the purpose of the present invention is to provide a method for preparing crisaborole, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]benzonitrile using cheap and readily available salicylaldehyde as a starting material. The method of the present invention has low cost, few side reactions, high yield, mild reaction conditions, cheap and readily available raw materials and reagents, simple post-treatment, and is environmentally friendly, thus meeting the needs of industrial production.

[0017] In order to achieve the above object, the technical solution adopted by the present invention is as follows:

[0018] A preparation method of crisaborole comprises the steps:

[0019] S1, using salicylaldehyde (Formula I) as a raw material, undergoing a substitution reaction with bromine under the action of a catalyst to obtain 5-bromosalicylaldehyde (Formula II);

[0020] S2, 5-bromosalicylaldehyde (Formula II) reacts with an OTf reagent in a solvent in the presence of a base to obtain 2-trifluoromethanesulfonate-5-bromobenzaldehyde (Formula III);

[0021] S3, 2-trifluoromethanesulfonate-5-bromobenzaldehyde (Formula III) undergoes etherification reaction with p-hydroxybenzonitrile in the presence of a base and a solvent to obtain 4-(3-formyl-4-trifluoromethanesulfonate phenoxy)benzonitrile (Formula IV);

[0022] S4, 4-(3-formyl-4-trifluoromethanesulfonate phenoxy)benzonitrile (Formula IV) reacts with biboric acid pinacol ester under alkaline conditions and a palladium catalyst to obtain 4-(4-nitrile phenoxy)-2-formylphenylboric acid pinacol ester (Formula V);

[0023] S5, 4-(4-nitrilephenoxy)-2-formylphenylboronic acid pinacol ester (Formula V) is reduced by an alkali metal borohydride and then cyclized under acidic conditions to give crisaborole (Formula VI).

[0024] The present invention adopts a method of first forming ether and then cyclizing, wherein the OTf reagent is used to protect the hydroxyl group; secondly, to form a borate ester group, introduce a boron atom, avoid bromine or hydroxyl from participating in the borate esterification reaction, and effectively reduce the increase of side reactions and impurities (such as self-condensation impurities caused by bromine) caused by the hydroxyl or bromine in the borate esterification reaction.

[0025] The raw material 2-bromo-5-hydroxybenzaldehyde used in the prior art, phenolic hydroxyl and aldehyde group will undergo self-condensation under alkaline conditions, and will also undergo self-condensation with bromine at the same time, with many side reactions and low yield, so it is necessary to protect hydroxyl or aldehyde group. The 2-hydroxy-5-bromobenzaldehyde (Formula II) in the present invention is different from the raw material 2-bromo-5-hydroxybenzaldehyde group position used in the prior art, and the main purpose is that the present invention does not need to protect aldehyde group under subsequent alkaline conditions, and the exposed group is bromine after OTfization, which can avoid self-condensation of hydroxyl and aldehyde group. At the same time, in the following etherification reaction, phenolic hydroxyl will form alcohol anion under alkaline conditions, so as to attack the carbon positive center of aryl halide, and aryl halide will be removed after halogen and ether support will be formed by nucleophilic substitution, OTf is a strong electron-withdrawing group, which is more conducive to the departure of bromine, and the etherification reaction speed is faster and the yield is higher; In addition, the present invention also unexpectedly finds that the reaction time is too long and the yield will decrease.

[0026] In a preferred embodiment, in step S1, salicylaldehyde and bromine undergo a substitution reaction in anhydrous ethanol; the reaction temperature is 5-15°C, and the reaction time is 2-3 hours; the molar ratio of salicylaldehyde to bromine is 1:0.95-1.05; the catalyst includes PEG-400, and the molar ratio of the catalyst PEG-400 to salicylaldehyde is 1:0.01-0.05.

[0027] In a preferred embodiment, in step S2, the reaction temperature is 0-50°C, and the reaction time is 2-4h; the OTf reagent is N-phenylbis(trifluoromethanesulfonyl)imide or trifluoromethanesulfonic anhydride; the molar ratio of the compound of formula II to the OTf reagent is 1:1.05-1.15; the solvent is DMF, DMSO, DMA, NMP, THF or DCM; and the base is potassium carbonate, sodium carbonate, cesium carbonate, DIPEA or TEA.

[0028] In a preferred embodiment, in step S3, the molar ratio of the compound of formula III to p-hydroxybenzonitrile is 1:1.0-1.3; the base is potassium carbonate, sodium carbonate or cesium carbonate; the solvent is DMF, DMSO, DMA, THF or DCM; the etherification reaction temperature is 80° C., and the reaction time is 2-4 h.

[0029] In a preferred embodiment, in step S4, the palladium catalyst is one or more of Pd(PPh3)4, Pd(PPh3)2Cl2, Pd(dppf)Cl2, Pd(dba)2 and palladium acetate; the molar ratio of the palladium catalyst to the compound of formula IV is 1:40-80; the molar ratio of the compound of formula IV to diboric acid pinacol ester is 1:1.0-3.0; the reaction temperature is 70-100°C; and the reaction time is 8-12h.

[0030] In a preferred embodiment, in step S5, the molar ratio of the compound of formula V to the alkali metal borohydride is 1:0.8-1.2; the alkali metal borohydride is sodium borohydride and / or potassium borohydride; the solvent is at least one of methanol, ethanol, isopropanol, water and tetrahydrofuran; the reduction reaction time is 0.5-1.5h, and the reduction reaction temperature is 5-5°C; the cyclization reaction time is 30min, and the cyclization reaction temperature is 10-20°C.

[0031] Furthermore, in step S1, the reaction temperature is 8-12°C; the molar ratio of salicylaldehyde to bromine is 1:0.98-1.02; the molar ratio of the catalyst PEG-400 to salicylaldehyde is 1:0.02-0.03;

[0032] In step S2, the reaction temperature is 20-30°C, the OTf reagent is N-phenylbis(trifluoromethanesulfonyl)imide; the molar ratio of the compound of formula II to N-phenylbis(trifluoromethanesulfonyl)imide is 1:1.08-1.12, the solvent is THF, and the base is TEA.

[0033] More preferably, in step S3, the molar ratio of the compound of formula III to p-hydroxybenzonitrile is 1:1.15, the base is sodium carbonate, the solvent is DMF, and the reaction time is 2 to 4 hours.

[0034] Furthermore, in step S4, the palladium catalyst is Pd(dppf)Cl2, the molar ratio of the compound of formula IV to diboric acid pinacol ester is 1:1.5-2, the reaction temperature is 80-100°C, and the reaction time is 12-15h.

[0035] More preferably, in step S5, the molar ratio of the compound of formula V to the alkali metal borohydride is 1:1; the alkali metal borohydride is sodium borohydride; the solvent is methanol; the reduction reaction time is 1 hour, and the cyclization reaction time is 30 minutes.

[0036] In a preferred embodiment, the specific reaction process is as follows:

[0037]

[0038] Compared with the prior art, the invention is beneficial in that: using cheap and readily available salicylaldehyde as a starting material, an intermediate II is prepared by bromination reaction, the intermediate II is trifluoromethanesulfonated to prepare an intermediate III, the intermediate III is etherified to prepare an intermediate IV, the intermediate IV is borated to prepare an intermediate V, and the intermediate V is reduced and cyclized to prepare criborole. The method of the invention greatly reduces the cost of raw materials, has a high yield, avoids the participation of hydroxyl or bromine in the borate esterification reaction, has few side reactions, has a high product purity, has mild reaction conditions, is simple in post-treatment, is environmentally friendly, and can meet the needs of industrial production. DETAILED DESCRIPTION

[0039] The present invention is described in detail below with reference to specific embodiments.

[0040] The yields in the following examples are calculated based on the molar number of the substrate fed in each specific step.

[0041]

[0042] Add salicylaldehyde (24.4g, 0.20mmol) and 200mL of anhydrous ethanol to the reaction bottle. After stirring evenly, add PEG-400 (2.0g), slowly drop Br2 (32g, 0.20mol) / 50ml of anhydrous ethanol mixed solution, control the reaction temperature at 10-12℃, monitor by TLC, and the reaction is completed after 2.5h. Add 250ml of deionized water to the solution, gradually precipitate a white precipitate, stir and crystallize for 2h. Filter by suction, and recrystallize the obtained wet product with 200ml of anhydrous ethanol / water (volume ratio 1:1) to obtain 38.4g of white filamentous crystals of 5-bromosalicylaldehyde (Formula II), with a yield of 95.5% and a purity of 99.0%.

[0043] Example 2: Preparation of 2-trifluoromethanesulfonate-5-bromobenzaldehyde (Formula III)

[0044]

[0045] In a reaction flask, a mixture of 5-bromosalicylaldehyde (Formula II) (6.48 g, 30 mmol), PhN(Tf)2 (11.79 g, 33 mmol) and triethylamine (6.06 g, 60 mmol) was stirred in 60 ml of THF (tetrahydrofuran) at room temperature for 3 hours. The solution was diluted with ethyl acetate and washed three times with water. The organic layer was dried over anhydrous MgSO4 and evaporated to dryness. The crude product was purified on silica gel (gradient 10:1->1:1) to give 10.26 g of oily compound III (29.4 mmol, yield 98%, purity 99.5%).

[0046] Example 3: Preparation of 2-trifluoromethanesulfonate-5-bromobenzaldehyde (Formula III)

[0047]

[0048] 5-bromo salicylaldehyde (Formula II) (2.16 g, 10 mmol), triethylamine (2.02 g, 20 mmol), 20 ml DCM were added to the reaction flask, Tf2O (5.64 g, 20 mmol) was added dropwise at low temperature, and stirred at room temperature for 3 hours. The solution was diluted with ethyl acetate and washed with water three times. The organic layer was dried over anhydrous MgSO4 and evaporated to dryness. The crude product was purified on silica gel (gradient 10:1->1:1) to obtain 3.34 g of oily compound III (9.6 mmol, yield 96%, purity 99.5%).

[0049] Example 4: Preparation of 4-(3-formyl-4-trifluoromethanesulfonate phenoxy)benzonitrile (Formula IV)

[0050]

[0051] 2-Trifluoromethanesulfonate-5-bromobenzaldehyde (Formula III) (3.42 g, 9.8 mmol), 4-hydroxybenzonitrile (1.41 g, 11.8 mmol), N,N-dimethylformamide DMF (20 mL), and potassium carbonate (1.63 g, 11.8 mmol) were added to the reaction flask in sequence, stirred at room temperature to dissolve, and the mixed solution was heated to 80°C and reacted for 3 h. DMF was removed under reduced pressure, and the residue was diluted with EtOAc (100 mL), then washed with water (20 mL) and saturated brine (20 mL), dried over sodium sulfate, filtered, concentrated, and purified to obtain the product 4-(3-formyl-4-trifluoromethanesulfonate phenoxy)benzonitrile (Formula IV) 3.2 g, 8.62 mmol, with a yield of 88% and a purity of 99.4%.

[0052] Example 5: Preparation of 4-(3-formyl-4-trifluoromethanesulfonate phenoxy)benzonitrile (Formula IV)

[0053]

[0054] 2-Trifluoromethanesulfonate-5-bromobenzaldehyde (Formula III) (3.42 g, 9.8 mmol), 4-hydroxybenzonitrile (1.41 g, 11.8 mmol), DCM (20 mL), and sodium carbonate (1.25 g, 11.8 mmol) were added to the reaction flask in sequence, stirred at room temperature to dissolve, and the mixture was heated to 80°C and reacted for 3 h. DMF was removed under reduced pressure, and the residue was diluted with EtOAc (100 mL), then washed with water (20 mL) and saturated brine (20 mL), dried over sodium sulfate, filtered, concentrated, and purified to obtain the product 4-(3-formyl-4-trifluoromethanesulfonate phenoxy)benzonitrile (Formula IV) 3.28 g, 8.82 mmol, with a yield of 90% and a purity of 99.0%.

[0055] Comparative Example 1: Preparation of 4-(3-formyl-4-trifluoromethanesulfonate phenoxy)benzonitrile (Formula IV)

[0056]

[0057] 2-Trifluoromethanesulfonate-5-bromobenzaldehyde (Formula III) (3.42 g, 9.8 mmol), 4-hydroxybenzonitrile (1.41 g, 11.8 mmol), DCM (20 mL), and sodium carbonate (1.25 g, 11.8 mmol) were added to the reaction flask in sequence, stirred at room temperature to dissolve, and the mixture was heated to 80°C and reacted for 24 h. DMF was removed under reduced pressure, and the residue was diluted with EtOAc (100 mL), then washed with water (20 mL) and saturated brine (20 mL), dried over sodium sulfate, filtered, concentrated, and purified to obtain the product 4-(3-formyl-4-trifluoromethanesulfonate phenoxy)benzonitrile (Formula IV) 2.73 g, 7.35 mmol, with a yield of 75% and a purity of 96.5%.

[0058] Example 6: Preparation of 4-(4-nitrile phenoxy)-2-formylphenylboronic acid pinacol ester (Formula V)

[0059]

[0060] Under nitrogen protection, 4-(3-formyl-4-trifluoromethanesulfonate phenoxy)benzonitrile (IV) (3.2 g, 8.62 mmol), potassium carbonate (2.38 g, 17.24 mol), biboric acid pinacol ester (3.28 g, 12.93 mol), PdCl2(dppf)2 (0.12 g, 0.17 mmol), 30 ml DMF were added to a reaction bottle, the temperature of the reaction mixture was raised to 100 ° C, the reaction was carried out for 12 hours, and the reaction was completed. The temperature of the reaction mixture was lowered to room temperature, 60 ml of water was added, and the mixture was stirred in an ice-water bath for 2 hours, and the mixture was filtered under reduced pressure, and then the filter cake was dissolved, and silica gel was added to remove the palladium in the reaction by adsorption, and 2.41 g, 6.90 mmol, the yield was 80%, and the purity was 99.0%.

[0061] Example 7: Preparation of 4-(4-nitrile phenoxy)-2-formylphenylboronic acid pinacol ester (Formula V)

[0062]

[0063] Under nitrogen protection, 4-(3-formyl-4-trifluoromethanesulfonate phenoxy)benzonitrile (IV) (3.2 g, 8.62 mmol), potassium carbonate (2.38 g, 17.24 mol), biboric acid pinacol ester (3.28 g, 12.93 mol), Pd(PPh3)2Cl2 (0.12 g, 0.17 mmol), 30 ml DMF were added to a reaction bottle, the temperature of the reaction mixture was raised to 100 ° C, the reaction was carried out for 12 hours, and the reaction was completed. The temperature of the reaction mixture was lowered to room temperature, 60 ml of water was added, and the mixture was stirred for 2 hours under ice water bath, and the mixture was filtered under reduced pressure, and then the filter cake was dissolved, and silica gel was added to remove the palladium in the reaction by adsorption, and 2.46 g, 7.06 mmol, the yield was 82%, and the purity was 98.5%.

[0064] Example 8: Preparation of Clisborole (Formula VI)

[0065]

[0066] Under nitrogen protection, add 4-(4-nitrile phenoxy)-2-formylphenylboronic acid pinacol ester (V) (2.41 g, 6.90 mmol) to a reaction bottle containing 30 ml of methanol, slowly cool to -5 ° C, stir to dissolve, then slowly add reducing agent sodium borohydride (0.26 g, 6.90 mmol), stir and react at -5 ° C for 1 h. The reaction mixture is concentrated under reduced pressure at a temperature below 45 ° C, and the obtained residue is dissolved in a mixture of ethyl acetate and water. The reaction mixture is cooled to about 10 ° C, and the pH of the reaction mixture is adjusted to about 4.0 with 4M hydrochloric acid, and stirred for 30 min. The two layers are separated, and the organic layer is concentrated under reduced pressure below 45 ° C and degassed at about 45 ° C. Wash with methanol / water, then wash with dimethyl sulfoxide / water, and dry the wet product at about 45-55 ° C. A white solid of 1.3 g, 5.18 mmol, a yield of 75%, and a HPLC purity of 99.8% is obtained.

[0067] Example 9: Preparation of Clisborole (Formula VI)

[0068]

[0069] Under nitrogen protection, add 4-(4-nitrile phenoxy)-2-formylphenylboronic acid pinacol ester (V) (2.41 g, 6.90 mmol) to a reaction bottle containing 30 ml of methanol, slowly cool to an internal temperature of 5°C, stir to dissolve, then slowly add reducing agent potassium borohydride (0.37 g, 6.90 mmol), stir and react at 5°C for 1 h. The reaction mixture is concentrated under reduced pressure at a temperature below 45°C, and the obtained residue is dissolved in a mixture of ethyl acetate and water. The reaction mixture is cooled to about 20°C, and the pH of the reaction mixture is adjusted to about 6.0 with 4M hydrochloric acid, and stirred for 30 min. The two layers are separated, and the organic layer is concentrated under reduced pressure below 45°C and degassed at about 45°C. Wash with methanol / water, then with dimethyl sulfoxide / water, and dry the wet product at about 45-55°C. A white solid of 1.4 g, 5.55 mmol, with a yield of 80.5% and a HPLC purity of 98.9% is obtained.

[0070] In the description of the present invention, reference to terms such as "embodiment", "specific example" or "practical application" means that the specific features, structures, materials or characteristics described in combination with the embodiment are included in at least one embodiment or example of the present invention; the schematic expressions of the above terms do not necessarily refer to the same embodiment or example, and the specific features, structures, materials or characteristics described may be combined in an appropriate manner in any one or more embodiments or examples.

[0071] The above embodiments are only used to illustrate the technical solutions of the present invention. Those skilled in the art should understand that the above embodiments do not limit the present invention in any form, and any technical solutions obtained by equivalent replacement or equivalent transformation shall fall within the protection scope of the present invention.

Claims

1. A method for preparing crisaborole, characterized in that: The steps include: S1, using salicylaldehyde (Formula I) as a raw material, undergoing a substitution reaction with bromine under the action of a catalyst to obtain 5-bromosalicylaldehyde (Formula II); S2, 5-bromosalicylaldehyde (Formula II) reacts with an OTf reagent in a solvent in the presence of a base to obtain 2-trifluoromethanesulfonate-5-bromobenzaldehyde (Formula III); S3, 2-trifluoromethanesulfonate-5-bromobenzaldehyde (Formula III) undergoes etherification reaction with p-hydroxybenzonitrile in the presence of a base and a solvent to obtain 4-(3-formyl-4-trifluoromethanesulfonate phenoxy)benzonitrile (Formula IV); S4, 4-(3-formyl-4-trifluoromethanesulfonate phenoxy)benzonitrile (Formula IV) reacts with biboric acid pinacol ester under alkaline conditions and a palladium catalyst to obtain 4-(4-nitrile phenoxy)-2-formylphenylboric acid pinacol ester (Formula V); S5, 4-(4-nitrilephenoxy)-2-formylphenylboronic acid pinacol ester (Formula V) is reduced by an alkali metal borohydride and then cyclized under acidic conditions to give crisaborole (Formula VI).

2. The method for preparing crisaborole according to claim 1, characterized in that: In step S1, salicylaldehyde and bromine undergo substitution reaction in anhydrous ethanol; the reaction temperature is 5-15° C., and the reaction time is 2-3 hours; the molar ratio of salicylaldehyde to bromine is 1:0.95-1.05; the catalyst includes PEG-400, and the molar ratio of the catalyst PEG-400 to salicylaldehyde is 1:0.01-0.

05.

3. The method for preparing crisaborole according to claim 1, characterized in that: In step S2, the reaction temperature is 0-50° C., and the reaction time is 2-4 h; the OTf reagent is N-phenylbis(trifluoromethanesulfonyl)imide or trifluoromethanesulfonic anhydride; the molar ratio of the compound of formula II to the OTf reagent is 1:1.05-1.15; the solvent is DMF, DMSO, DMA, NMP, THF or DCM; and the base is potassium carbonate, sodium carbonate, cesium carbonate, DIPEA or TEA.

4. The method for preparing crisaborole according to claim 1, characterized in that: In step S3, the molar ratio of the compound of formula III to p-hydroxybenzonitrile is 1:1.0-1.3; the base is potassium carbonate, sodium carbonate or cesium carbonate; the solvent is DMF, DMSO, DMA, THF or DCM; the etherification reaction temperature is 80° C., and the reaction time is 2-4 h.

5. The method for preparing crisaborole according to claim 1, characterized in that: In step S4, the palladium catalyst is one or more of Pd(PPh3)4, Pd(PPh3)2Cl2, Pd(dppf)Cl2, Pd(dba)2 and palladium acetate; the molar ratio of the palladium catalyst to the compound of formula IV is 1:40-80; the molar ratio of the compound of formula IV to bipyraclostrobin is 1:1.0-3.0; the reaction temperature is 70-100°C; and the reaction time is 8-12h.

6. The method for preparing crisaborole according to claim 1, characterized in that: In step S5, the molar ratio of the compound of formula V to the alkali metal borohydride is 1:0.8-1.2; the alkali metal borohydride is sodium borohydride and / or potassium borohydride; the solvent is at least one of methanol, ethanol, isopropanol, water and tetrahydrofuran; the reduction reaction time is 0.5-1.5h, and the reduction reaction temperature is 5-5°C; the cyclization reaction time is 30min, and the cyclization reaction temperature is 10-20°C.

7. The method for preparing crisaborole according to claim 2 or 3, characterized in that: In step S1, the reaction temperature is 8-12°C; the molar ratio of salicylaldehyde to bromine is 1:0.98-1.02; the molar ratio of the catalyst PEG-400 to salicylaldehyde is 1:0.02-0.03; In step S2, the reaction temperature is 20-30°C, the OTf reagent is N-phenylbis(trifluoromethanesulfonyl)imide; the molar ratio of the compound of formula II to N-phenylbis(trifluoromethanesulfonyl)imide is 1:1.08-1.12, the solvent is THF, and the base is TEA.

8. The method for preparing crisaborole according to claim 4, characterized in that: In step S3, the molar ratio of the compound of formula III to p-hydroxybenzonitrile is 1:1.15, the base is sodium carbonate, the solvent is DMF, and the reaction time is 2 to 4 hours.

9. The method for preparing crisaborole according to claim 5, characterized in that: In step S4, the palladium catalyst is Pd(dppf)Cl2, the molar ratio of the compound of formula IV to bipyraclostrobin is 1:1.5-2, the reaction temperature is 80-100°C, and the reaction time is 12-15h.

10. The method for preparing crisaborole according to claim 6, characterized in that: In step S5, the molar ratio of the compound of formula V to the alkali metal borohydride is 1:1; the alkali metal borohydride is sodium borohydride; the solvent is methanol; the reduction reaction time is 1 hour, and the cyclization reaction time is 30 minutes.